JPS6250471B2 - - Google Patents
Info
- Publication number
- JPS6250471B2 JPS6250471B2 JP54042347A JP4234779A JPS6250471B2 JP S6250471 B2 JPS6250471 B2 JP S6250471B2 JP 54042347 A JP54042347 A JP 54042347A JP 4234779 A JP4234779 A JP 4234779A JP S6250471 B2 JPS6250471 B2 JP S6250471B2
- Authority
- JP
- Japan
- Prior art keywords
- culture
- medium
- properties
- streptomyces
- antibiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
- C12P17/184—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4234779A JPS55136282A (en) | 1979-04-06 | 1979-04-06 | Novel antibiotic pa-31088-4 |
| US06/115,278 US4292241A (en) | 1979-04-06 | 1980-01-25 | Antibiotic PA-31088-IV and production thereof |
| CA000345633A CA1153968A (en) | 1979-04-06 | 1980-02-14 | Antibiotic pa-31088-iv and production thereof |
| AU56037/80A AU528686B2 (en) | 1979-04-06 | 1980-02-29 | Antibiotic pa-31088-iv |
| EP80101825A EP0017246B1 (en) | 1979-04-06 | 1980-04-03 | Antibiotic pa-31088-iv, its salts with bases, a process for its manufacture, pharmaceutical compositions containing this antibiotic, streptomyces tokunonensis pa-31088 and its mutants |
| DE8080101825T DE3067408D1 (en) | 1979-04-06 | 1980-04-03 | Antibiotic pa-31088-iv, its salts with bases, a process for its manufacture, pharmaceutical compositions containing this antibiotic, streptomyces tokunonensis pa-31088 and its mutants |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4234779A JPS55136282A (en) | 1979-04-06 | 1979-04-06 | Novel antibiotic pa-31088-4 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS55136282A JPS55136282A (en) | 1980-10-23 |
| JPS6250471B2 true JPS6250471B2 (enExample) | 1987-10-24 |
Family
ID=12633486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4234779A Granted JPS55136282A (en) | 1979-04-06 | 1979-04-06 | Novel antibiotic pa-31088-4 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4292241A (enExample) |
| EP (1) | EP0017246B1 (enExample) |
| JP (1) | JPS55136282A (enExample) |
| AU (1) | AU528686B2 (enExample) |
| CA (1) | CA1153968A (enExample) |
| DE (1) | DE3067408D1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01134170A (ja) * | 1987-11-19 | 1989-05-26 | Matsushita Electric Ind Co Ltd | 冷凍サイクルの安全装置 |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5683489A (en) * | 1979-12-12 | 1981-07-08 | Shionogi & Co Ltd | New antibiotic pa-39504-x1 and it preparation |
| JPS5740485A (en) * | 1980-08-25 | 1982-03-06 | Shionogi & Co Ltd | Novel antibiotic pa-39504-x3 and its preparation |
| JPS5764693A (en) * | 1980-10-07 | 1982-04-19 | Kowa Co | Novel carbapenem compound and its preparation |
| ES8302711A1 (es) * | 1980-10-24 | 1983-02-01 | Kowa Co | Proceso de produccion de un compuesto medicamentoso que con-tiene antibioticos de la serie ka-6643 |
| JPS57176982A (en) * | 1981-04-24 | 1982-10-30 | Shionogi & Co Ltd | Dioxolanylazetidinone compound, its preparation and use |
| DE3146190A1 (de) * | 1981-11-21 | 1983-06-16 | Hoechst Ag, 6230 Frankfurt | Isolierung von chemisch instabilen antibiotika aus fermentationsloesungen |
| NZ213963A (en) * | 1984-10-27 | 1989-01-06 | Antibioticos Sa | Production of clavulanic acid |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4172129A (en) * | 1974-03-28 | 1979-10-23 | Beecham Group Limited | Antibiotics |
| GB1483142A (en) | 1975-03-15 | 1977-08-17 | Beecham Group Ltd | Streptomycetal antibiotic |
| NL7802826A (nl) * | 1977-04-08 | 1978-10-10 | Merck & Co Inc | Thienamycinederivaat, werkwijze voor het bereiden daarvan, alsmede farmaceutische preparaten. |
| AU531084B2 (en) * | 1977-10-19 | 1983-08-11 | Merck & Co., Inc. | Azetidine derivatives |
| DE2862419D1 (en) * | 1977-11-12 | 1984-07-26 | Beecham Group Plc | Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates |
| EP0005349A1 (en) * | 1978-05-06 | 1979-11-14 | Beecham Group Plc | Alkylcarbapenems, their preparation, use in pharmaceutical compositions and intermediates |
-
1979
- 1979-04-06 JP JP4234779A patent/JPS55136282A/ja active Granted
-
1980
- 1980-01-25 US US06/115,278 patent/US4292241A/en not_active Expired - Lifetime
- 1980-02-14 CA CA000345633A patent/CA1153968A/en not_active Expired
- 1980-02-29 AU AU56037/80A patent/AU528686B2/en not_active Ceased
- 1980-04-03 EP EP80101825A patent/EP0017246B1/en not_active Expired
- 1980-04-03 DE DE8080101825T patent/DE3067408D1/de not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01134170A (ja) * | 1987-11-19 | 1989-05-26 | Matsushita Electric Ind Co Ltd | 冷凍サイクルの安全装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0017246A1 (en) | 1980-10-15 |
| JPS55136282A (en) | 1980-10-23 |
| CA1153968A (en) | 1983-09-20 |
| DE3067408D1 (en) | 1984-05-17 |
| AU5603780A (en) | 1980-10-09 |
| US4292241A (en) | 1981-09-29 |
| AU528686B2 (en) | 1983-05-12 |
| EP0017246B1 (en) | 1984-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4560552A (en) | Antibiotics | |
| US4110165A (en) | Process for the production of clavulanic acid | |
| US3950357A (en) | Antibiotics | |
| US6218380B1 (en) | Pharmaceutical compositions | |
| US6048977A (en) | Clavulanic acid and salts thereof | |
| US4529720A (en) | Antibiotic from Streptomyces clavulicerus | |
| US4006060A (en) | Thienamycin production | |
| JPS631315B2 (enExample) | ||
| JPS6250471B2 (enExample) | ||
| JPS599155B2 (ja) | 抗生物質 | |
| US4060530A (en) | Clavulanic acid amides | |
| US4525353A (en) | Antibiotics | |
| US4140764A (en) | β-Lactamase inhibitors and process for their preparation | |
| US4229534A (en) | Acetylthienamycin production | |
| US4165379A (en) | N-acetyl thienamycin | |
| US4304867A (en) | Culture of Streptomyces cattleya | |
| EP0046596B1 (en) | Antibiotic pa-39504-x3, process for its production and pharmaceutical compositions | |
| US4061649A (en) | Clavulanic acid sulphates | |
| US4123540A (en) | Isoclavulanic acid as an antibacterial and a β-lactamase inhibitor | |
| US4081548A (en) | Antibiotics | |
| JPH0361662B2 (enExample) | ||
| JPS58891A (ja) | 新規抗生物質pa−41746−aおよびその製造法 | |
| JPS6210640B2 (enExample) | ||
| JPS58116485A (ja) | 新規抗生物質カルバペネム誘導体およびその製造法 | |
| JPS62174099A (ja) | 新規グリコペプチド系抗生物質pa−42867−aおよびpa−42867−bとその製造方法 |